日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction: Circulating tumor DNA refines consolidation immunotherapy for limited-stage small cell lung cancer patients

更正:循环肿瘤DNA可优化局限期小细胞肺癌患者的巩固免疫疗法

Yang, Yin; Wu, Yuqi; Zhao, Jingjing; Zhang, Tao; Fei, Kailun; Zhao, Xiaotian; Deng, Lei; Zhang, Zhihui; Jiang, Ying; Wang, Jianyang; Liu, Wenyang; Wang, Xin; Wang, Song; Bao, Hua; Wu, Xue; Zhu, Minyi; Ou, Qiuxiang; Tang, Wei; Wang, Luhua; Wang, Zhijie; Bi, Nan

Multimodal deep learning for survival prediction and biomarker discovery in non-small cell lung cancer

多模态深度学习在非小细胞肺癌生存预测和生物标志物发现中的应用

Wang, Yiqing; Xia, Pinghui; Xu, Yang; Xu, Jianxin; Xu, Wenzhen; Lv, Wang; Yan, Junrong; Ou, Qiuxiang; Bao, Hua; Wang, Luming; Hu, Jian

From fields to eyes: the epidemiology and immune challenges of fungal keratitis

从田野到眼睛:真菌性角膜炎的流行病学和免疫挑战

Li, Yu; Zhang, Xiao-Lu; Huang, Bao-Hua; Zhao, Qi; Gu, Yu-Feng

Transcriptomic and metabolomic response of the Xunhua pepper landrace to BBWV2 infection in Qinghai Province, China

中国青海省迅化辣椒地方品种对BBWV2感染的转录组和代谢组响应

Qin, Shu; Mengnan, Bao; Hua, Weng; Jiahui, Yan

Decoding resistance in Diutina catenulata by validating clinically relevant Erg11/Fks1 mutations

通过验证具有临床意义的 Erg11/Fks1 突变来解码 Diutina catenulata 的耐药性

Zhang, Wei; Wang, Na; Chen, Xin-Fei; He, Bao-Hua; Xiao, Meng; Xu, Ying-Chun; Li, Qi

Characterizing the molecular and clinical implications of NRG1 fusions in NSCLC through integrated RNA and DNA sequencing analysis

通过整合RNA和DNA测序分析,阐明NRG1融合在非小细胞肺癌中的分子和临床意义

Fan, Yue; Zhang, Chenglu; Zhu, Minyi; Xu, Yang; Tang, Haimeng; Pang, Jiaohui; Bao, Hairong; Ou, Qiuxiang; Bao, Hua; Xu, Bei

A nomogram for predicting fetal growth restriction in patients with preeclampsia based on complete blood count results at 20-24 weeks of gestation: a retrospective case-control study in China

基于妊娠20-24周全血细胞计数结果预测先兆子痫患者胎儿生长受限的列线图:一项中国回顾性病例对照研究

Li, Na; Shu, Shu-Juan; Wang, Miao-Miao; Xu, Shu-Hang; Huang, Xiao-Xiu; Li, Bao-Hua

EGFR A859S alteration may predict a better response to third-generation EGFR-TKI treatment in advanced NSCLC

EGFR A859S 突变可能预示晚期非小细胞肺癌患者对第三代 EGFR-TKI 治疗的疗效更佳。

Hong, Weiping; Fu, Wenfan; Ma, Ya; Wang, Chenxuan; Xu, Yang; Yin, Jiani; Pang, Jiaohui; Ou, Qiuxiang; Bao, Hua; Gu, Jincui; Li, Baoxiu

The differences in molecular profiles and survival outcomes between early-onset and late-onset glioblastoma multiforme

早发型和晚发型胶质母细胞瘤的分子特征和生存结果的差异

Wei, Yukui; Wu, Xiaolong; Bao, Hua; Xiao, Yao; Diao, Huantong; Liu, Siheng; Shan, Bingyang; Ding, Peng; Cheng, Ye; Xiao, Xinru

Circulating tumor DNA refines consolidation immunotherapy for limited-stage small cell lung cancer patients

循环肿瘤DNA可优化局限期小细胞肺癌患者的巩固免疫疗法

Yang, Yin; Wu, Yuqi; Zhao, Jingjing; Zhang, Tao; Fei, Kailun; Zhao, Xiaotian; Deng, Lei; Zhang, Zhihui; Jiang, Ying; Wang, Jianyang; Liu, Wenyang; Wang, Xin; Wang, Song; Bao, Hua; Wu, Xue; Zhu, Minyi; Ou, Qiuxiang; Tang, Wei; Wang, Luhua; Wang, Zhijie; Bi, Nan